1/26
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
3 requirements to be a NT
1) production and storage in presynaptic neuron
2) release upon stimulation
3) experimental results yield same effect as presynaptic release
Dale’s principle, is it correct?
only a single NT is released by a neuron - wrong
Diffuse modulatory systems
small number of neurons that manufacture and release NT, connected to rest of brain through axons
Cholinergic neurons: diffuse modulatory systems
basal forebrain complex
medial septum —> hippocampus: memory formation, spatial
basal nucleus of Meynert —> rest: arousal, mood
pontomesencephalotegmental complex —> dorsal thalamus: sensory relay
Cholinergic neurons: production
Acetyl-CoA + choline —> Acetylcholine (use choline acetyltransferase ChAT)
in membrane —> gets packed up into vesicles by ACh transporter
choline: rate-limiting factor, can be increased through diet
Cholinergic neurons: deactivation
free-floating acetylcholinesterase (AChE) break down ACh to acetic acid and choline
choline reuptake through choline transporter (activated by Na+ gradient)
AChE produced in glial cells
Catecholaminergenic neurons
1) Dopaminergic (Dopamine)
2) Noradrenergic (Norepinephrine)
3) Adrenergic (Epinephrine)
Dopaminergic neurons: diffuse modulatory systems
Susbtantia Nigra —> basal ganglia: voluntary movement
ex) Parkinson’s disease
Ventral tegmental area —> frontal lobe: reward pathways, desire
rat experiment
Dopaminergic neurons: production
Tyrosine —> l-dopa (Tyrosine Hydroxylase) —> Dopamine (dopa decarboxylase)
TH: rate limiting factor 1) higher AP and Ca2+ concentration in cell stimulate production of TH 2) decreased catecholamine release increase cellular concentration of catecholamines —> less TH produced
What is used to treat Parkinsons? Why is it ineffective in the long term?
l-dopa, which creates an abundance of dopamine in the basal ganglia, but overtime this abundance causes the brain to downregulate production of dopamine
Dopaminergic neurons: reuptake
DAT in presynaptic neurons and astrocytes take dopamine —> Monoamine Oxide (MAO) breakdown dopamine in mitochondria and liver
MAO inhibitors are antidepressants
explain mechanism of cocaine
Blocks DAT —> dopamine stays in synaptic cleft for longer
explain mechanism of amphetamines
1) enters presynaptic neuron through DAT
2) reverses VMAT → dopamine flows out of vesicle into the cytoplasm
3) reverses DAT → cytoplasmic dopamine flows out to the synaptic cleft
→ increased release of dopamine
Noradrenergic neurons: diffuse modulatory system
Locus coeruleus (LC) → rest of the brain
1 neuron → 250,000 neurons
mood, awakeness, sleep cycle, arousal
stress response, response to new stimuli
Noradrenergic: production
Dopamine → norepinephrine (DBH)
created in vesicles
Adrenergic
Norepinephrine → epinephrine (PNMT)
synthesized in cytosol
Serotonergic neurons: diffuse modulatory system
Raphe nuclei
→ caudal: pain
→ rostral: mood, sleep/wake cycle
Serotonergic neurons: production
Tryptophan → 5-HTP (tryptophan hydroxylase) → 5-HT
rate limiting factor: tryptophan - in food
Serotonergic neurons: deactivation
reuptake through SERT (plasma membrane serotonergic transporters)
reused
target of SSRI (selective serotonin reuptake inhibitors)
Serotonin (5-HT) regulation
through 5-HT 1d receptors in presynaptic neuron that downregulates the production of 5-HT when 5-HT binds to it
Why do SSRIs take a while to work?
due to the regulation by 5-HT 1d receptors. It takes a while for the abundance of serotonin to cause desensitization of 5-HT 1d receptors
Amino Acidergic Neurons: production
Glutamine → Glutamate (Glutaminase) → GABA (GAD)
GAD only expressed in GABAergic neurons → can be used as a marker
packaging by vGlut and vGAT
Glutamate
primary excitatory NT
GABA
primary inhibitory NT
Amino acidergic neurons: deactivation
reuptake to presynaptic cells or astrocytes
Glutamate: EAAT
GABA: GAT
→ converted to glutamine and recycled in neurons
Endocannabinoids
retrograde messengers: high concentration of NT in synaptic cleft → high concentration of Ca2+ in postsynaptic cell → activation of enzyme that makes endocannabinoids → travel to cannabinoid receptor in presynaptic neuron → triggers downregulation of NT synthesis or release
manufactured on demand
membrane permeable
Nitric Oxide
vasodilation
long term potentiation: learning and memory
regulate Glu/GABA activity
retrograde messenger